ArticleCancers2019

Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma.

Rachel E Doherty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.